RECRUITING

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

Talk to us

Conditions

ObesityStem Cell Transplant

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Pilot study enrolling obese post HSCT (hematopoietic stem cell transplantation) patients at the hematology/oncology clinic at the Mattel Children's Hospital, University of California, Los Angeles. Parameters include percent over the 95th percentile (%BMIp95), zBMI, fasting metabolic metrics, addictive eating habits, and motivation for change.

Official Title

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

Quick Facts

Study Start:2021-08-15
Study Completion:2024-11-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04997473

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:13 Years to 30 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients ≥ 13 and ≤ 30 years old with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study.
  2. * Both male and female patients will be eligible.
  3. * Patients must classify as obese, represented as Body mass index \[BMI\] ≥85th percentile for age and gender.
  4. * Patients must also be able to read English since the app intervention is only available in English form.
  1. * Patients who are ≤ 13 or ≥ 30 years old are not eligible for the study.
  2. * Patients who are \< 100 days post-transplant at initial consultation will not be eligible for the study, but may become eligible if they are \>100 days post-transplant at their next consultation that falls within the enrollment window.
  3. * Patients whose BMI does not fall under the obese category will be excluded.
  4. * No patients will be excluded for any specific underlying medical condition, but decisions will be made on a case by case basis if a patient's functioning is deemed to significantly interfere with intervention participation.

Contacts and Locations

Study Contact

Andres Vargas
CONTACT
3108256742
andresvargas@mednet.ucla.edu

Principal Investigator

Theodore B Moore, MD
PRINCIPAL_INVESTIGATOR
UCLA Health

Study Locations (Sites)

UCLA Mattel Children's Hospital
Los Angeles, California, 90095
United States

Collaborators and Investigators

Sponsor: University of California, Los Angeles

  • Theodore B Moore, MD, PRINCIPAL_INVESTIGATOR, UCLA Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-08-15
Study Completion Date2024-11-30

Study Record Updates

Study Start Date2021-08-15
Study Completion Date2024-11-30

Terms related to this study

Additional Relevant MeSH Terms

  • Obesity
  • Stem Cell Transplant